Angiogene Incorporated

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Antiproliferative Therapeutics Drug Discovery Cardiovascular Diseases Oncology Radio

Contact Details: 1851 Sherbrooke E. Suite 704 Montreal Quebec H2K 4L5 United Kingdom Tel: (514) 596-1111 Fax: (514) 596-1119 Email: WWW: www.angiogene.com/

Recent Publications by Angiogene Incorporated:
32P-oligodeoxynucleotide-coated coils to prevent arterial recanalization after embolization. BACKGROUND AND PURPOSE: Endovascular treatment of aneurysms with coils, a...	5th October, 2004	Angiogene Inc., Montreal, Quebec, Canada.	AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):1062-6.
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Physiological differences between tumor and normal vasculature provide a...	29th January, 2003	Angiogene Pharmaceuticals Ltd., Oxford Science Park, Oxford, United	Cancer Res. 2002 Dec 15;62(24):7247-53.
Enhancement of vascular targeting by inhibitors of nitric oxide synthase. PURPOSE: This study investigates the enhancement of the vascular targeting...	3rd January, 2003	Angiogene Pharmaceuticals	Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1532-6.

Angiogene Incorporated Patents:
US Patent No.	Title
7265136	Substituted stilbene compounds with vascular damaging activity
6339071	Antisense oligonucleotide modulating cyclin E gene expression and therapeutic uses thereof
6423753	Use of colchinol derivatives as vascular damaging agents
6626928	Occlusion device for treating aneurysm and use therefor
6645950	Benzimidazole vascular damaging agents
→View more Angiogene Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 192 times since April 2007, the link to the organisation's website has been followed 53 times

Recent Search Terms used to find this page: www.angiogene.com | www.angiogene.com | 1851 sherbrooke suite 704 | Angiogene Oxford science park | angiogene.com | angiogene.com/ | angiogene | angiogene | angiogene | .

Search for more companies in Montreal

Search for more companies in Quebec

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Angiogene Incorporated

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.